Kruse TA - Search Results

Year	Number of Results
1978	1
1980	2
1981	3
1982	1
1984	1
1986	3
1987	2
1988	5
1989	3
1990	1
1991	6
1992	6
1994	9
1995	10
1996	4
1997	5
1998	7
1999	6
2000	3
2001	5
2002	10
2003	6
2004	11
2005	10
2006	18
2007	10
2008	11
2009	8
2010	8
2011	16
2012	19
2013	10
2014	14
2015	9
2016	11
2017	14
2018	12
2019	11
2020	7
2021	3
2022	7
2023	3
2024	2

1

Ensemble-based classification using microRNA expression identifies a breast cancer patient subgroup with an ultralow long-term risk of metastases.

Block I, Burton M, Sørensen KP, Larsen MJ, Do TTN, Bak M, Cold S, Thomassen M, Tan Q, Kruse TA. Block I, et al. Among authors: kruse ta. Cancer Med. 2024 May;13(9):e7089. doi: 10.1002/cam4.7089. Cancer Med. 2024. PMID: 38676390 Free PMC article.

2

Male with an apparently normal phenotype carrying a BRCA1 exon 20 duplication in trans to a BRCA1 frameshift variant.

Block I, Mateu-Regué À, Do TTN, Miceikaite I, Sdogati D, Larsen MJ, Hao Q, Nielsen HR, Boonen SE, Skytte AB, Jensen UB, Høffding LK, De Nicolo A, Viel A, Tudini E, Parsons MT, Hansen TVO, Rossing M, Kruse TA, Spurdle AB, Thomassen M. Block I, et al. Among authors: kruse ta. Breast Cancer Res. 2024 Jan 9;26(1):6. doi: 10.1186/s13058-023-01755-9. Breast Cancer Res. 2024. PMID: 38195559 Free PMC article.

3

Whole blood transcriptional profiling reveals highly deregulated atherosclerosis genes in Philadelphia-chromosome negative myeloproliferative neoplasms.

Skov V, Thomassen M, Kjaer L, Larsen MK, Knudsen TA, Ellervik C, Kruse TA, Hasselbalch HC. Skov V, et al. Among authors: kruse ta. Eur J Haematol. 2023 Nov;111(5):805-814. doi: 10.1111/ejh.14081. Epub 2023 Aug 28. Eur J Haematol. 2023. PMID: 37640394

4

Non-BRCA1/BRCA2 high-risk familial breast cancers are not associated with a high prevalence of BRCAness.

Andersen LVB, Larsen MJ, Davies H, Degasperi A, Nielsen HR, Jensen LA, Kroeldrup L, Gerdes AM, Lænkholm AV, Kruse TA, Nik-Zainal S, Thomassen M. Andersen LVB, et al. Among authors: kruse ta. Breast Cancer Res. 2023 Jun 14;25(1):69. doi: 10.1186/s13058-023-01655-y. Breast Cancer Res. 2023. PMID: 37316882 Free PMC article.

5

Differential expression of checkpoint markers in the normoxic and hypoxic microenvironment of glioblastomas.

Petterson SA, Sørensen MD, Burton M, Thomassen M, Kruse TA, Michaelsen SR, Kristensen BW. Petterson SA, et al. Among authors: kruse ta. Brain Pathol. 2023 Jan;33(1):e13111. doi: 10.1111/bpa.13111. Epub 2022 Sep 12. Brain Pathol. 2023. PMID: 36093941 Free PMC article.

6

Clinical, splicing, and functional analysis to classify BRCA2 exon 3 variants: Application of a points-based ACMG/AMP approach.

Thomassen M, Mesman RLS, Hansen TVO, Menendez M, Rossing M, Esteban-Sánchez A, Tudini E, Törngren T, Parsons MT, Pedersen IS, Teo SH, Kruse TA, Møller P, Borg Å, Jensen UB, Christensen LL, Singer CF, Muhr D, Santamarina M, Brandao R, Andresen BS, Feng BJ, Canson D, Richardson ME, Karam R, Pesaran T, LaDuca H, Conner BR, Abualkheir N, Hoang L, Calléja FMGR, Andrews L, James PA, Bunyan D, Hamblett A, Radice P, Goldgar DE, Walker LC, Engel C, Claes KBM, Macháčková E, Baralle D, Viel A, Wappenschmidt B, Lazaro C, Vega A; ENIGMA Consortium; Vreeswijk MPG, de la Hoya M, Spurdle AB. Thomassen M, et al. Among authors: kruse ta. Hum Mutat. 2022 Dec;43(12):1921-1944. doi: 10.1002/humu.24449. Epub 2022 Oct 23. Hum Mutat. 2022. PMID: 35979650 Free PMC article.

7

A Signature of Exaggerated Adipose Tissue Dysfunction in Type 2 Diabetes Is Linked to Low Plasma Adiponectin and Increased Transcriptional Activation of Proteasomal Degradation in Muscle.

Sabaratnam R, Skov V, Paulsen SK, Juhl S, Kruse R, Hansen T, Halkier C, Kristensen JM, Vind BF, Richelsen B, Knudsen S, Dahlgaard J, Beck-Nielsen H, Kruse TA, Højlund K. Sabaratnam R, et al. Among authors: kruse ta. Cells. 2022 Jun 23;11(13):2005. doi: 10.3390/cells11132005. Cells. 2022. PMID: 35805088 Free PMC article.

8

Interferon-alpha2 treatment of patients with polycythemia vera and related neoplasms favorably impacts deregulation of oxidative stress genes and antioxidative defense mechanisms.

Skov V, Thomassen M, Kjær L, Ellervik C, Larsen MK, Knudsen TA, Kruse TA, Hasselbalch HC. Skov V, et al. Among authors: kruse ta. PLoS One. 2022 Jun 30;17(6):e0270669. doi: 10.1371/journal.pone.0270669. eCollection 2022. PLoS One. 2022. PMID: 35771847 Free PMC article.

9

Heterogeneity and tumor evolution reflected in liquid biopsy in metastatic breast cancer patients: a review.

Kavan S, Kruse TA, Vogsen M, Hildebrandt MG, Thomassen M. Kavan S, et al. Among authors: kruse ta. Cancer Metastasis Rev. 2022 Jun;41(2):433-446. doi: 10.1007/s10555-022-10023-9. Epub 2022 Mar 14. Cancer Metastasis Rev. 2022. PMID: 35286542 Review.

10

Comparison of the Metastasis Predictive Potential of mRNA and Long Non-Coding RNA Profiling in Systemically Untreated Breast Cancer.

Do TTN, Block I, Burton M, Sørensen KP, Larsen MJ, Bak M, Cold S, Thomassen M, Tan Q, Kruse TA. Do TTN, et al. Among authors: kruse ta. Cancers (Basel). 2021 Sep 29;13(19):4907. doi: 10.3390/cancers13194907. Cancers (Basel). 2021. PMID: 34638391 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

287 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

287 results

Results by year